Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 生命科學院
  3. 生命科學系
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/66814
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor嚴震東
dc.contributor.authorHao-Jin Wangen
dc.contributor.author王皓瑾zh_TW
dc.date.accessioned2021-06-17T01:08:47Z-
dc.date.available2020-02-10
dc.date.copyright2020-02-10
dc.date.issued2020
dc.date.submitted2020-01-22
dc.identifier.citation1. Baron, R.; Binder, A.; Wasner, G., Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. The Lancet Neurology 2010, 9 (8), 807-819.
2. Jensen, T. S.; Baron, R.; Haanpää, M.; Kalso, E.; Loeser, J. D.; Rice, A. S. C.; Treede, R.-D., A new definition of neuropathic pain. Pain 2011, 152 (10), 2204-2205.
3. Lauria, G.; Cornblath, D. R.; Johansson, O.; McArthur, J. C.; Mellgren, S. I.; Nolano, M.; Rosenberg, N.; Sommer, C., EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur. J. Neurol. 2005, 12 (10), 747-758.
4. Lauria, G.; Lombardi, R.; Camozzi, F.; Devigili, G., Skin biopsy for the diagnosis of peripheral neuropathy. Histopathology 2009, 54 (3), 273-285.
5. MacIver, M. B.; Tanelian, D. L., Free nerve ending terminal morphology is fiber type specific for A delta and C fibers innervating rabbit corneal epithelium. J. Neurophysiol. 1993, 69 (5), 1779-83.
6. Messlinger, K., Chapter 17. Functional morphology of nociceptive and other fine sensory endings (free nerve endings) in different tissues. In Prog. Brain Res., Kumazawa, T.; Kruger, L.; Mizumura, K., Eds. Elsevier: 1996; Vol. 113, pp 273-298.
7. Kandel, E. R.; Schwartz, J. H.; Jessell, T. M.; Biochemistry, D. o.; Jessell, M. B. T.; Siegelbaum, S.; Hudspeth, A., Principles of neural science. McGraw-hill New York: 2000; Vol. 4.
8. Graham, J.; Muhsin, M.; Kirkpatrick, P., Oxaliplatin. Nature Publishing Group: 2004.
9. Van Cutsem, E.; Rivera, F.; Berry, S.; Kretzschmar, A.; Michael, M.; DiBartolomeo, M.; Mazier, M.-A.; Canon, J.-L.; Georgoulias, V.; Peeters, M., Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann. Oncol. 2009, 20 (11), 1842-1847.
10. Gebremedhn, E. G.; Shortland, P. J.; Mahns, D. A., The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review. BMC Cancer 2018, 18 (1), 410-410.
11. Webster, R. G.; Brain, K. L.; Wilson, R. H.; Grem, J. L.; Vincent, A., Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels. British journal of pharmacology 2005, 146 (7), 1027-1039.
12. Kawashiri, T.; Egashira, N.; Kurobe, K.; Tsutsumi, K.; Yamashita, Y.; Ushio, S.; Yano, T.; Oishi, R., L type Ca 2+ channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats. Mol. Pain 2012, 8 (1), 7.
13. Nassini, R.; Gees, M.; Harrison, S.; De Siena, G.; Materazzi, S.; Moretto, N.; Failli, P.; Preti, D.; Marchetti, N.; Cavazzini, A., Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation. PAIN® 2011, 152 (7), 1621-1631.
14. Starobova, H.; Vetter, I., Pathophysiology of chemotherapy-induced peripheral neuropathy. Front. Mol. Neurosci. 2017, 10, 174.
15. Huang, J.; Yang, Y.; Zhao, P.; Gerrits, M. M.; Hoeijmakers, J. G. J.; Bekelaar, K.; Merkies, I. S. J.; Faber, C. G.; Dib-Hajj, S. D.; Waxman, S. G., Small-Fiber Neuropathy Na<sub>v</sub>1.8 Mutation Shifts Activation to Hyperpolarized Potentials and Increases Excitability of Dorsal Root Ganglion Neurons. The Journal of Neuroscience 2013, 33 (35), 14087-14097.
16. Shields, S. D.; Ahn, H.-S.; Yang, Y.; Han, C.; Seal, R. P.; Wood, J. N.; Waxman, S. G.; Dib-Hajj, S. D., Nav1.8 expression is not restricted to nociceptors in mouse peripheral nervous system. PAIN® 2012, 153 (10), 2017-2030.
17. Renganathan, M.; Cummins, T. R.; Waxman, S. G., Contribution of Nav1.8 Sodium Channels to Action Potential Electrogenesis in DRG Neurons. J. Neurophysiol. 2001, 86 (2), 629-640.
18. Blair, N. T.; Bean, B. P., Roles of Tetrodotoxin (TTX)-Sensitive Na<sup>+</sup> Current, TTX-Resistant Na<sup>+</sup> Current, and Ca<sup>2+</sup> Current in the Action Potentials of Nociceptive Sensory Neurons. The Journal of Neuroscience 2002, 22 (23), 10277-10290.
19. Luiz, A.; MacDonald, D.; Santana-Varela, S.; Millet, Q.; Sikandar, S.; Wood, J.; Emery, E., Cold sensing by NaV1. 8-positive and NaV1. 8-negative sensory neurons. Proceedings of the National Academy of Sciences 2019, 116 (9), 3811-3816.
20. Lin, S. H.; Steinhoff, M.; Ikoma, A.; Chang, Y. C.; Cheng, Y. R.; Chandra Kopparaju, R.; Ishii, S.; Sun, W. H.; Chen, C. C., Involvement of TRPV1 and TDAG8 in Pruriception Associated with Noxious Acidosis. J Invest Dermatol 2017, 137 (1), 170-178.
21. Jerremalm, E.; Hedeland, M.; Wallin, I.; Bondesson, U.; Ehrsson, H., Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex. Pharm. Res. 2004, 21 (5), 891-894.
22. Ta, L. E.; Low, P. A.; Windebank, A. J., Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli. Mol. Pain 2009, 5 (1), 9.
23. Douillard, J.-Y.; Siena, S.; Cassidy, J.; Tabernero, J.; Burkes, R.; Barugel, M.; Humblet, Y.; Bodoky, G.; Cunningham, D.; Jassem, J., Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J. Clin. Oncol. 2010, 28 (31), 4697-4705.
24. Stanford, S. C., The open field test: reinventing the wheel. J. Psychopharm. 2007, 21 (2), 134-136.
25. Gould, T. D.; Dao, D. T.; Kovacsics, C. E., The Open Field Test. In Mood and Anxiety Related Phenotypes in Mice: Characterization Using Behavioral Tests, Gould, T. D., Ed. Humana Press: Totowa, NJ, 2009; pp 1-20.
26. Chaplan, S. R.; Bach, F.; Pogrel, J.; Chung, J.; Yaksh, T., Quantitative assessment of tactile allodynia in the rat paw. Journal of neuroscience methods 1994, 53 (1), 55-63.
27. Brenner, D. S.; Golden, J. P.; Gereau IV, R. W., A novel behavioral assay for measuring cold sensation in mice. PloS one 2012, 7 (6), e39765.
28. Boyette-Davis, J.; Dougherty, P. M., Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline. Exp. Neurol. 2011, 229 (2), 353-357.
29. Burakgazi, A.; Messersmith, W.; Vaidya, D.; Hauer, P.; Hoke, A.; Polydefkis, M., Longitudinal assessment of oxaliplatin-induced neuropathy. Neurology 2011, 77 (10), 980-986.
30. Krøigård, T.; Schrøder, H. D.; Qvortrup, C.; Eckhoff, L.; Pfeiffer, P.; Gaist, D.; Sindrup, S. H., Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies. Eur. J. Neurol. 2014, 21 (4), 623-629.
31. Xiao, W. H.; Zheng, H.; Bennett, G. J., Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel. Neuroscience 2012, 203, 194-206.
32. Krøigård, T.; Svendsen, T. K.; Wirenfeldt, M.; Schrøder, H. D.; Qvortrup, C.; Pfeiffer, P.; Gaist, D.; Sindrup, S. H., Early changes in tests of peripheral nerve function during oxaliplatin treatment and their correlation with chemotherapy‐induced polyneuropathy symptoms and signs. Eur. J. Neurol. 2019.
33. Dong, X.-W.; Goregoaker, S.; Engler, H.; Zhou, X.; Mark, L.; Crona, J.; Terry, R.; Hunter, J.; Priestley, T., Small interfering RNA-mediated selective knockdown of NaV1. 8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic rats. Neuroscience 2007, 146 (2), 812-821.
34. Lolignier, S.; Eijkelkamp, N.; Wood, J. N., Mechanical allodynia. Pflügers Archiv - European Journal of Physiology 2015, 467 (1), 133-139.
35. Descoeur, J.; Pereira, V.; Pizzoccaro, A.; Francois, A.; Ling, B.; Maffre, V.; Couette, B.; Busserolles, J.; Courteix, C.; Noel, J.; Lazdunski, M.; Eschalier, A.; Authier, N.; Bourinet, E., Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. EMBO Mol. Med. 2011, 3 (5), 266-278.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/66814-
dc.description.abstract周邊神經病變(peripheral neuropathy) 所引起的神經性疼痛 (neuropathic pain)會嚴重影響病患的生活品質,常見於疾病的症狀或者治療的副作用,例如:糖尿病患者晚期的慢性疼痛,以及癌症化療造成的末肢疼痛。無論是在臨床或是實驗室中,只有少數方法可用於了解末梢神經纖維狀況,如組織切片(tissue biopsy)或定量感覺測試(Quantitative sensory testing)。這些方法皆有其自身的缺陷和局限,例如:造成開放性傷口,或只能觀察行為間接獲得周邊神經的健康狀況。
  本研究基於我們實驗室使用的Nav1.8-cre-Tdtomato小鼠和共聚焦顯微鏡所發展而成的方法,有別於傳統活體組織切片或者以測定行為等間接的方式去了解周邊神經的狀況,此方式不僅可以在不造成開放性傷口的情況下直接觀察周圍神經纖維在皮下的狀態,還可以在特定皮膚區域在不同時間點進行連續的實時追蹤。結合癌症化療藥物奧沙利鉑引起的疼痛模型,本實驗目標在於以活體實時觀察周邊皮下神經纖維之方式研究奧沙利鉑引起的異常疼痛與皮下感覺神經型態學上的干係。
 在施打了奧沙利鉑後,在曠野實驗中小鼠移動距離明顯下降,且在機械痛實驗中施打奧沙利鉑的小鼠有明顯疼痛,然而小鼠後腳皮下鈉離子電位感測型通道1.8表現型(Nav1.8)有表現的神經不論是長度或是體積皆沒有顯著性變化。本篇發現化療引起的機械性疼痛不是由於皮下感覺神經退化所引起,可能造成異常疼痛的原因有細胞膜上膜離子通道表現型改變進而造成痛覺異常等。
zh_TW
dc.description.abstractNeuropathic pain caused by peripheral neuropathy can severely affect the patient's quality of life. It is often found in the disease symptoms or medical treatment side effects, such as chronic pain in the advanced stages of diabetes and cancer chemotherapy neuropathic pain. Neither clinical or laboratory, only few methods can exam terminal neuron fibres status, like tissue biopsy or Quantitative sensory testing (QST). All these methods have its own defects and limits, such as skin damage and indirectly approaching.
 This study is based on a method developed by the Nav1.8-cre-Tdtomato mouse and confocal microscope used in our laboratory. Our method not only directly observe the state of the peripheral nerve fibres under the skin without causing an open wound, but also continuously track in real time at different time points in specific skin area.
 After oxaliplatin injection, mouse behavior changed but nerve morphology remained consistent. In open field test, locomotor activities droped in week 2 and 3. Anxiety also developed after oxaliplatin treatment. In von Frey test, mice developed severe mechanical allodynia in week 1, 2, and 3. By our in vivo image, results show either Nav1.8 expressed cutaneous nerve length or volume remained consistent under oxaliplatin treatment.
 All results indicate that oxaliplatin induced mechanical allodynia has no relation with cutaneous nerves morphology change. Mechanical allodynia may be caused by remodeling expression of ion channels or oxidative stress in cell body, which we cannot approach by this method.
en
dc.description.provenanceMade available in DSpace on 2021-06-17T01:08:47Z (GMT). No. of bitstreams: 1
ntu-109-R06b21026-1.pdf: 3397557 bytes, checksum: 235eb174a3a0eb7f3eb61d9a8a018812 (MD5)
Previous issue date: 2020
en
dc.description.tableofcontents致謝 i
摘要 1
Abstract 2
Introduction 4
Oxaliplatin induced peripheral neuropathy 5
Role of Nav1.8 expressed neuron 6
Aim 7
Material and Methods 8
Animals 8
Drugs treatment 8
Mice health control 9
Behavioral testing 10
Intra-vital confocal microscopic image 13
Image processing and quantification 13
Statistical analysis 17
Results 18
General toxicity and mice body weight 18
Open field test 19
Mechanical and cold allodynia 19
Nerve length and volume change 20
Discussion 22
Figures 25
Reference 41
dc.language.isoen
dc.subject化療引起之周邊神經病變zh_TW
dc.subject奧沙利鉑zh_TW
dc.subject活體影像zh_TW
dc.subject表皮神經纖維密度zh_TW
dc.subject鈉離子電位感測型通道1.8轉基因小鼠zh_TW
dc.subjectChemotherapy induced peripheral neuropathy (CIPN)en
dc.subjectOxaliplatinen
dc.subjectIntra-vital imagingen
dc.subjectIntraepidermal nerve fibre density (IENFD)en
dc.subjectNav1.8 transgenic miceen
dc.title觀察小鼠在施打奧沙力鉑後引起的疼痛反應以及周邊神經變化zh_TW
dc.titleVisualizing Nociceptor Changes in Mice with Oxaliplatin-induced Peripheral Neuropathyen
dc.typeThesis
dc.date.schoolyear108-1
dc.description.degree碩士
dc.contributor.oralexamcommittee劉佩珊,邱瑞珍
dc.subject.keyword化療引起之周邊神經病變,奧沙利鉑,活體影像,表皮神經纖維密度,鈉離子電位感測型通道1.8轉基因小鼠,zh_TW
dc.subject.keywordChemotherapy induced peripheral neuropathy (CIPN),Oxaliplatin,Intra-vital imaging,Intraepidermal nerve fibre density (IENFD),Nav1.8 transgenic mice,en
dc.relation.page47
dc.identifier.doi10.6342/NTU202000236
dc.rights.note有償授權
dc.date.accepted2020-01-22
dc.contributor.author-college生命科學院zh_TW
dc.contributor.author-dept生命科學系zh_TW
顯示於系所單位:生命科學系

文件中的檔案:
檔案 大小格式 
ntu-109-1.pdf
  未授權公開取用
3.32 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved